MOGAD Mimicking CNS Infection in an Adolescent: A Case Report
An adolescent presenting with acute neurological deterioration was initially evaluated for a central nervous system infection before clinicians identified myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), according to a case report published in Cureus. The diagnostic challenge highlights the overlapping clinical features between autoimmune demyelinating conditions and infectious meningoencephalitis in pediatric populations, which can complicate acute management and therapeutic selection.
Key Clinical Takeaways:
- MOGAD can clinically mimic central nervous system infections in adolescents, presenting diagnostic hurdles that risk delayed immunotherapy.
- Autoimmune demyelinating disorders require careful differentiation from acute viral or bacterial pathogens through advanced neuroimaging and biomarker testing.
- Timely identification of myelin oligodendrocyte glycoprotein antibodies prevents misadministration of inappropriate antimicrobial regimens and directs targeted immunosuppressive protocols.
Diagnostic Overlap Between Autoimmune Demyelination and CNS Infection
Differentiating acute disseminated encephalomyelitis or MOGAD from infectious meningoencephalitis remains a significant hurdle in emergency pediatric neurology. Patients frequently present with fever, headache, altered mental status, and focal neurological deficits, symptoms common to both inflammatory demyelination and acute central nervous system pathogens. According to the findings detailed in Cureus, clinicians must maintain a broad differential diagnosis when initial cerebrospinal fluid profiles and neuroimaging present ambiguous markers.
The pathogenesis of MOGAD involves immune-mediated attacks directed against the myelin oligodendrocyte glycoprotein expressed on the surface of myelin sheaths within the central nervous system. This inflammatory cascade disrupts signal conduction and yields lesions that can closely resemble infectious abscesses or viral encephalitis on magnetic resonance imaging. Prompt referral to a specialized pediatric neuroimmunology center is vital to ensure accurate antibody testing via cell-based assays rather than relying solely on conventional clinical criteria.
Clinical Triage and Management Strategies for Pediatric MOGAD
Managing suspected autoimmune demyelination requires an expedited diagnostic workflow to minimize long-term neurological morbidity. When standard infectious disease panels return negative results in the face of progressive encephalopathy, treating physicians must evaluate serum or cerebrospinal fluid for MOG-IgG antibodies. Misdiagnosing this immune-mediated condition as a refractory infection can lead to prolonged, ineffective antimicrobial therapy while delaying essential corticosteroid or plasma exchange interventions.
For healthcare institutions navigating complex pediatric neuroinflammatory presentations, establishing protocolized pathways with specialized diagnostic laboratories ensures rapid assay turnaround times. Coordinating care through a multidisciplinary team involving board-certified pediatric neurologists helps optimize acute immunotherapy regimens and supports long-term functional recovery for adolescent patients.
As clinical awareness of MOGAD expands, future protocols will likely integrate standardized biomarker screening earlier in the evaluation of acute pediatric encephalopathy. Refining these diagnostic algorithms will reduce time-to-treatment and improve clinical outcomes for adolescents presenting with complex neuroinflammatory phenotypes. Clinicians managing atypical presentations are encouraged to consult with vetted specialists via the Global Medical Directory to secure immediate expert guidance.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.